Evidence map›Paper›PMID 29237843›Full record

ArticleJournal of virology2018

Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.

Wei Zou, Zekun Wang, Min Xiong, Aaron Yun Chen, Peng Xu, Safder S Ganaie, Yomna Badawi, Steve Kleiboeker, Hiroshi Nishimune, Shui Qing Ye and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Structures and implications of the nuclease domain of human parvovirus B19 NS1 protein.Computational and structural biotechnology journal · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Wei ZouDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Zekun WangDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Min XiongDepartment of Pediatrics and Department of Biomedical and Health Informatics, The Children's Mercy Hospital and University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
Aaron Yun ChenDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Peng XuDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Safder S GanaieDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Yomna BadawiDepartment of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Steve KleiboekerViraCor Eurofins Laboratories, Lee's Summit, Missouri, USA.
Hiroshi NishimuneDepartment of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Shui Qing YeDepartment of Pediatrics and Department of Biomedical and Health Informatics, The Children's Mercy Hospital and University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
Jianming QiuDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA jqiu@kumc.edu.
University of Kansas Medical Center · USUniversity of Missouri–Kansas City · USEurofins (United States) · US

Funding

Using PCORnet to Expand the DS-CONNECT Cohort Through Healthcare System Recruitment, Incorporating Electronic Health Records, and Assessing Self-DeterminationU54HD090216 · NICHD · UNIVERSITY OF KANSAS LAWRENCE · PI COLOMBO, JOHN A. · 2016 to 2020
$6.2M
Novel Approaches for the Control of Microbial PathogensP30GM103326 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LUTKENHAUS, JOSEPH F · 2012 to 2016
$5.3M
Post-Transcriptional Regulation of Parvovirus Capsid Gene ExpressionR01AI070723 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI QIU, JIANMING · 2007 to 2017
$3.3M
Exercise-activated mechanisms reduce degeneration of aged neuromuscular junctionsR01AG051470 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MERINEY, STEPHEN D, NISHIMUNE, HIROSHI · 2015 to 2019
$1.9M
Active zone loss cause dying back neuropathy in amyotrophic lateral sclerosisR01NS078214 · NINDS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NISHIMUNE, HIROSHI · 2012 to 2016
$1.6M
NIAID NIH HHS R01 AI070723NIA NIH HHS R01 AG051470NICHD NIH HHS U54 HD090216NIGMS NIH HHS P30 GM103326NINDS NIH HHS R01 NS078214
6 · The paper itself

Abstract

Human parvovirus B19 (B19V) infection of human erythroid progenitor cells (EPCs) induces a DNA damage response and cell cycle arrest at late S phase, which facilitates viral DNA replication. However, it is not clear exactly which cellular factors are employed by this single-stranded DNA virus. Here, we used microarrays to systematically analyze the dynamic transcriptome of EPCs infected with B19V. We found that DNA metabolism, DNA replication, DNA repair, DNA damage response, cell cycle, and cell cycle arrest pathways were significantly regulated after B19V infection. Confocal microscopy analyses revealed that most cellular DNA replication proteins were recruited to the centers of viral DNA replication, but not the DNA repair DNA polymerases. Our results suggest that DNA replication polymerase δ and polymerase α are responsible for B19V DNA replication by knocking down its expression in EPCs. We further showed that although RPA32 is essential for B19V DNA replication and the phosphorylated forms of RPA32 colocalized with the replicating viral genomes, RPA32 phosphorylation was not necessary for B19V DNA replication. Thus, this report provides evidence that B19V uses the cellular DNA replication machinery for viral DNA replication.

Indexed as

Cell DivisionDNA ReplicationHost-Pathogen InteractionsVirus ReplicationBromodeoxyuridineCD36 AntigensCell CycleCell Cycle CheckpointsCell LineDNA DamageDNA Polymerase betaDNA Polymerase IIIDNA RepairDNA, Single-StrandedDNA, ViralErythroid Precursor CellsBromodeoxyuridineCD36 AntigensDNA Polymerase betaDNA Polymerase IIIDNA, Single-StrandedDNA, ViralReplication Protein ARPA2 protein, humanDNA replicationparvovirusparvovirus B19

Identifiers

PMID29237843
PMCPMC5809726
OpenAlexW2771595656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.